Kathryn C. Zoon, Director at Emergent BioSolutions Inc. (EBS), sold 3,992 shares at $35.53 ($142K) on 2022-05-24, disclosed to the SEC on 2022-05-25.
Seasonal sale ($142k) by Director — this insider has traded EBS in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.53 | 1,996 | $71K | 50.0% |
| 2 | $35.53 | 1,996 | $71K | 50.0% |
| Total | $35.53 avg | 3,992 | $142K | 100% |
| Filing → |
| EBS | SELL | 2025-03-12 | $115K | — | Filing → |
| EBS | SELL | 2024-06-06 | $61K | — | Filing → |
| EBS | SELL | 2024-05-31 | $8K | — | Filing → |